The prevalence of hematologic and metabolic abnormalities during chronic kidney disease stages in different ethnic groups

Kidney International

Volumn 74, Issue 1, 2008, Pages 108-114

  Barbour, S J ^a   Er, L ^b,c   Djurdjev, O ^b,c   Karim, M A ^a,d   Levin, A ^a,b,c,d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BC Provincial Renal Agency   (Canada)

^c ST PAUL S HOSPITAL   (Canada)

^d FRASER HEALTH AUTHORITY   (Canada)

Author keywords

Anemia; Chronic kidney disease; Cohort study; Ethnic differences; Hyperparathyroidism; Staging

Indexed keywords

ANEMIA; ARTICLE; ASIAN; BLOOD DISEASE; CAUCASIAN; CHRONIC KIDNEY DISEASE; DISEASE SEVERITY; ETHNIC DIFFERENCE; ETHNIC GROUP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERPARATHYROIDISM; HYPERPHOSPHATEMIA; HYPOALBUMINEMIA; HYPOCALCEMIA; MAJOR CLINICAL STUDY; METABOLIC DISORDER; OUTCOMES RESEARCH; PREVALENCE; PRIORITY JOURNAL; SELF REPORT;

EID: 45249090344     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.151     Document Type: Article

References (20)

1. Stigant C, Stevens L, Levin A. Strategies for the care of adults with chronic kidney disease. CMAJ 2003; 168: 1553-1560.
2. Jungers P, Massy ZA, Nguyen KT et al. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. Nephrol Dial Transplant 1997; 12: 2597-2602.
3. Mann JF, Gerstein HC, Pogue J et al. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 2001; 134: 629-636.
4. Levin A, Foley R. Cardiovascular disease in chronic renal insufficiency. Am J Kidney Dis 2000; 36: S24-S30.
5. Levin A, Thompson CR, Ethier J et al. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis 1999; 34: 125-134.
6. Levin A, Djurdjev O, Duncan J et al. Haemglobin at time of referral prior to dialysis predicts survival: an association of haemoglobin with long-term outcomes. Nephrol Dial Transplant 2006; 21: 370-377.
7. Block G, Hulbert-Shearon T, Levin N et al. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998; 31: 607-617.
8. Block G, Port F. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: recommendations for a change in management. Am J Kidney Dis 2000; 35: 1226-1237.
9. Llach F. Hyperphosphatemia in end stage renal disease: pathophysiological consequences. Kidney Int Suppl 1999; 73: S31-S37.
10. Chertow G, Burke S, Raggi P. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002; 62: 245-252.
11. National Kidney Foundation. K/DOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 2006; 47(Suppl 3): S1-S146.
12. Torres A, Lorenzo V, Hernández D et al. Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH. Kidney Int 1995; 47: 1434-1442.
13. Rocco MV, Frankenfield DL, Frederick PR et al. Intermediate outcomes by race and ethnicity in peritoneal dialysis patients: results from the 1997 ESRD core indicators project. Peritoneal Dial Int 2000; 20: 328-335.
14. Owen W. Racial differences in incidence, outcome, and quality of life for African-Americans on hemodialysis. Blood Purif 1996; 14: 278-285.
15. Frankenfield DL, Ramirez SP, McClellan WM et al. Differences in intermediate outcomes for Asian and non-Asian adult hemodialysis patients in the United States. Kidney Int 2003; 64: 623-631.
16. Zuo L, Ma YC, Zhou YH et al. Application of GFR-estimating equations in Chinese patients with chronic kidney disease. Am J Kidney Dis 2005; 45: 463-472.
17. Ma YC, Zuo L, Chen JH et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 2006; 17: 2937-2944.
18. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
19. National Kidney Foundation. K/DOQI Clinical practice guideline for CKD. Am J Kidney Dis 2002; 39: S1-S266.
20. Komenda P, Bealieu M, Seccombe D et al. Regional implementation of creatinine measurement standardization. J Am Soc Nephrol 2008; 19: 164-169.